Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

C. Twelves, W. Scheithauer, J. Mckendrick, J.-F. Seitz, Guy Van Hazel, A. Wong, E. Díaz-Rubio, F. Gilberg, J. Cassidy

    Research output: Contribution to journalArticlepeer-review

    130 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1190-1197
    JournalAnnals of Oncology
    Publication statusPublished - 2012

    Cite this